BrownJJLeverAFFraserR. Artifacts in the diagnosis of essential hypertension. In LaraghJHBühlerFRSeldinDW. Eds. Frontiers in hypertension research. New York: Springer Verlag, 1981;195–198.
2.
PadfieldPLBrownJJDaviesDL. The myth of idiopathic hyperaldosteronism. Lancet1981; 2:83–84.
3.
FraserRBeretta-PiccoliCBrownJJ. Response of aldosterone and 18-OH-hydroxy-corticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome and non-tumorous hyperaldosteronism. Hypertension1981; 3: suppl, 1:87–1:92.
4.
CollinsRDWeinbergerMHDowdyAJNokesGWGonzalesCMLuetscherJA. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension: Relation to plasma renin activity. J Clin Invest1970; 49:1415.
5.
Beretta-PicoliCDaviesDLBoddyK. Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci1982; in press.
6.
ConnJW. Plasma renin activity in primary aldosteronism: Importance in differential diagnosis and in research of essential hypertension. JAMA1964; 190:222.
7.
RandMJYangCCole-GoodwinHMMcCullochMWStoryDF. The operation of autoregulatory feedback loops in noradrenergic transmission to cardiovascular effector tissues. J Cardiovasc Pharmacol1981; 4 Suppl 1: 41.
8.
MajewskiHTungL-HRandMJ. Adrenaline-induced hypertension in rats. J Cardiovasc Pharmacol19813:179.
9.
Franco-MorselliRElghoziJLJolyEdi GiulioSMeyerP. Increased plasma adrenaline concentrations in benign essential hypertension. Br Med J1977; 2:1251.
10.
BrownMJMacquinI. Is adrenaline the cause of essential hypertension?Lancet1981; 2:1079.
